FDA’s Third-Party Inspection Program 'Here To Stay,' Agency Official Says

Despite slow growth, FDA's third-party Accredited Persons (AP) inspection program is "here to stay," an FDA official said. And a new agency initiative with Health Canada has sparked more interest in the use of third parties to perform FDA inspections

More from Archive

More from Medtech Insight